All Blogs

Oct 13, 2020

US/AZ deal; Alkermes’ Schizophrenia drug; Innovent/Lilly’s China market expansion; Rejection for Avenue


Oct 12, 2020

Market Drivers and Barriers That Will Shape The NMIBC Market In The Next Ten Years


Jun 30, 2025

Revolutionizing Schizophrenia Treatment: The Key Players Shaping the Future


Oct 08, 2020

Santhera flunks DMD phase 3; Scribe emerges with $20 M; Merck sells off Osteoarthritis drug to Novartis; Research updates on flu vaccine and glioblastoma


Oct 07, 2020

How do we curb the Opioid Epidemic?


Oct 06, 2020

MyoKardia buyout; Eidos acquisition; Amgen’s Aimovig; HCV discovery; Bharat Biotech’s Covaxin


Oct 05, 2020

Key Companies To Keep an Eye on for Pipeline Therapies in Osteosarcoma Market in the Next Decade


Oct 02, 2020

Pitfalls of Current Osteosarcoma Treatment Approaches


Oct 01, 2020

Brain’s immune cells research update; Moderna’s COVID-19 vaccine; Pfizer funnels $200 M into CStone; Myovant’s relugolix falls short in metastatic prostate cancer; Alnylam’s lumasiran phase 3 result


Sep 30, 2020

Conditions Medical Marijuana is Anticipated to be Prescribed in the Offing